These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23873267)

  • 1. Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature.
    Schwarze-Zander C; Klingmüller D; Klümper J; Strassburg CP; Rockstroh JK
    Infection; 2013 Dec; 41(6):1183-7. PubMed ID: 23873267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing's syndrome.
    Albert NE; Kazi S; Santoro J; Dougherty R
    Am J Med Sci; 2012 Jul; 344(1):72-4. PubMed ID: 22543594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 25513635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review.
    Song Y; Schroeder JR; Bush LM
    J Int Assoc Provid AIDS Care; 2014; 13(6):511-4. PubMed ID: 23778239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors.
    Fessler D; Beach J; Keel J; Stead W
    Pain Physician; 2012; 15(6):489-93. PubMed ID: 23159966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
    Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
    Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
    Foisy MM; Yakiwchuk EM; Chiu I; Singh AE
    HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir.
    Danaher PJ; Salsbury TL; Delmar JA
    Orthopedics; 2009 Jun; 32(6):450. PubMed ID: 19634808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient.
    Kedem E; Shahar E; Hassoun G; Pollack S
    J Asthma; 2010 Sep; 47(7):830-1. PubMed ID: 20653496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic Cushing syndrome and multifocal osteonecrosis caused by the interaction between inhaled fluticasone and ritonavir.
    Figueiredo J; Serrado M; Khmelinskii N; do Vale S
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32467117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir.
    Yombi JC; Maiter D; Belkhir L; Nzeusseu A; Vandercam B
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S79-82. PubMed ID: 18827959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
    Valin N; De Castro N; Garrait V; Bergeron A; Bouche C; Molina JM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):113-21. PubMed ID: 19270151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir.
    Jakeman B; Conklin J; Bouchonville M; Thornton K
    J Am Pharm Assoc (2003); 2015; 55(2):193-7. PubMed ID: 25658506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases.
    Samaras K; Pett S; Gowers A; McMurchie M; Cooper DA
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4394-8. PubMed ID: 15755851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iatrogenic Cushing's syndrome and osteoporosis due to an interaction between fluticasone and ritonavir.
    Azevedo L; Pêgo H; Souto Moura T; Germano I
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26516245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing syndrome due to ritonavir-fluticasone interaction.
    Canalejo E; Pacheco MS
    CMAJ; 2012 Oct; 184(15):1714. PubMed ID: 22586335
    [No Abstract]   [Full Text] [Related]  

  • 19. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
    St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
    AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary adrenal insufficiency from steroid use and co-prescribing of cytochrome p450 3A4 inhibitors.
    Williams D; Reicher I; Mohammed H; Richardson D
    HIV Med; 2019 May; 20(5):e10-e11. PubMed ID: 30924569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.